Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm
- 1 November 2024
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 161, 110123
Abstract
No abstract availableKeywords
This publication has 120 references indexed in Scilit:
- Chance Bias Arising from TSC2 Mutation Imbalance in the PREVeNT TrialAnnals of Neurology, 2023
- Assessing Liver Effects of Cannabidiol and Valproate Alone and in Combination Using Quantitative Systems ToxicologyClinical Pharmacology & Therapeutics, 2023
- The state of pediatric tuberous sclerosis complex epilepsy care: Results from a national surveyEpilepsia Open, 2022
- Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis ComplexJAMA Neurology, 2021
- Tuber Locations Associated with Infantile Spasms Map to a Common Brain NetworkAnnals of Neurology, 2021
- A survey of the European Reference Network EpiCARE on clinical practice for selected rare epilepsiesEpilepsia Open, 2020
- Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP TrialAnnals of Neurology, 2020
- Epilepsy in tuberous sclerosis complex: Findings from the TOSCA StudyEpilepsia Open, 2018
- Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disordersAnnals of Clinical and Translational Neurology, 2017
- Everolimus treatment of refractory epilepsy in tuberous sclerosis complexAnnals of Neurology, 2013